Literature DB >> 23426339

The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas.

Sandro Pasquali1, Lauren E Haydu, Richard A Scolyer, Julie B Winstanley, Andrew J Spillane, Michael J Quinn, Robyn P M Saw, Kerwin F Shannon, Jonathan R Stretch, John F Thompson.   

Abstract

OBJECTIVE: This study sought to investigate the impact of histopathologically measured excision margins and SNB on local and locoregional disease control in patients with primary cutaneous melanomas more than 4 mm thick.
BACKGROUND: Most current guidelines recommend at least a 2-cm surgical margin (which corresponds to a 16-mm histopathologic margin). These guidelines are based on limited evidence, mostly obtained in patients who did not have an SNB.
METHODS: Histopathologic tumor excision margins for clinically lymph node-negative patients with melanomas more than 4 mm thick, treated at Melanoma Institute Australia (1992-2009), were determined. Clinicopathologic predictors of local and locoregional disease-free survival were investigated.
RESULTS: There were 632 patients eligible for the study; of these, 397 (62.8%) had an SNB. The median histopathologic excision margin was 15 mm (interquartile range, 11.0-19.5 mm). After a median follow-up of 37 months, local and locoregional recurrences were observed in 48 (7.6%) and 159 (25.2%) patients, respectively. Excision margin as a continuous variable was a significant predictor of local [hazard ratio (HR), 0.91; P < 0.001) and locoregional (HR, 0.97; P = 0.042) tumor control on multivariate analyses. Patients with histopathologic margins 16 mm or less had worse local disease-free survival (HR, 2.41; P = 0.01). Patients who did not have an SNB were at higher risk of locoregional recurrence (HR, 1.67; P = 0.003).
CONCLUSIONS: Histopathologically determined primary tumor excision margins more than 16 mm, corresponding to 2-cm surgical margins, were associated with better local control in patients with melanomas more than 4 mm thick. Patients achieved the best local and locoregional control when SNB was coupled with a more than 16-mm histologic excision margin.

Entities:  

Mesh:

Year:  2013        PMID: 23426339     DOI: 10.1097/SLA.0b013e31828421e1

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  9 in total

1.  Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center.

Authors:  Alexander H R Varey; Chris Goumas; Angela M Hong; Graham J Mann; Gerald B Fogarty; Jonathan R Stretch; Robyn P M Saw; Andrew J Spillane; Kerwin F Shannon; Kenneth J Lee; Michael J Quinn; John F Thompson; Richard A Scolyer
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

Review 2.  CT, MRI and PET/CT features of abdominal manifestations of cutaneous melanoma: a review of current concepts in the era of tumor-specific therapies.

Authors:  Maxime Barat; Sarah Guegan-Bart; Anne-Ségolène Cottereau; Enora Guillo; Christine Hoeffel; Maximilien Barret; Sébastien Gaujoux; Anthony Dohan; Philippe Soyer
Journal:  Abdom Radiol (NY)       Date:  2020-11-02

Review 3.  Systemic treatments for metastatic cutaneous melanoma.

Authors:  Sandro Pasquali; Andreas V Hadjinicolaou; Vanna Chiarion Sileni; Carlo Riccardo Rossi; Simone Mocellin
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06

4.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

5.  Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group.

Authors:  João Pedreira Duprat; Eduard René Brechtbülh; Bianca Costa de Sá; Mauro Enokihara; Jose Humberto Fregnani; Gilles Landman; Marcus Maia; Felice Riccardi; Francisco Alberto Belfort; Alberto Wainstein; Luciana F Moredo; Higino Steck; Miguel Brandão; Marcelo Moreno; Eduardo Miranda; Ivan Dunshee de Oliveira Santos
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

6.  Desmoplastic Melanoma: Clinical Behavior and Management Implications.

Authors:  Collier S Pace; Jyoti P Kapil; Luke G Wolfe; Brian J Kaplan; James P Neifeld
Journal:  Eplasty       Date:  2016-01-11

7.  Melanoma-Derived BRAF(V600E) Mutation in Peritumoral Stromal Cells: Implications for in Vivo Cell Fusion.

Authors:  Zsuzsanna Kurgyis; Lajos V Kemény; Tünde Buknicz; Gergely Groma; Judit Oláh; Ádám Jakab; Hilda Polyánka; Kurt Zänker; Thomas Dittmar; Lajos Kemény; István B Németh
Journal:  Int J Mol Sci       Date:  2016-06-21       Impact factor: 5.923

Review 8.  Update and Review on the Surgical Management of Primary Cutaneous Melanoma.

Authors:  Solmaz Niknam Leilabadi; Amie Chen; Stacy Tsai; Vinaya Soundararajan; Howard Silberman; Alex K Wong
Journal:  Healthcare (Basel)       Date:  2014-06-10

9.  Surgery of primary tumor improves the survival of newly diagnosed metastatic melanoma: a population-based, propensity-matched study.

Authors:  Dongxiao Zhang; Yinjun Dong; Xiubin Sun; Shuanghu Yuan; Jinming Yu
Journal:  Cancer Manag Res       Date:  2018-12-27       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.